JPMorgan Chase & Co’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.2K | Sell |
|
|||||
|
2025
Q1 | $2.57M | Sell |
|
|||||
|
2024
Q4 | $4.92M | Sell |
|
|||||
|
2024
Q3 | $4.98M | Buy |
|
|||||
|
2024
Q2 | $8.27M | Buy |
|
|||||
|
2024
Q1 | $926K | Sell |
|
|||||
|
2023
Q4 | $1.02M | Sell |
|
|||||
|
2023
Q3 | $1.59M | Sell |
|
|||||
|
2023
Q2 | $2.29M | Buy |
|
|||||
|
2023
Q1 | $2.77M | Sell |
|
|||||
|
2022
Q4 | $2.29M | Sell |
|
|||||
|
2022
Q3 | $3.32M | Buy |
|
|||||
|
2022
Q2 | $2.19M | Buy |
|
|||||
|
2022
Q1 | $1.51M | Sell |
|
|||||
|
2021
Q4 | $4.3M | Sell |
|
|||||
|
2021
Q3 | $7.71M | Buy |
|
|||||
|
2021
Q2 | $7.72M | Buy |
|
|||||
|
2021
Q1 | $7.04M | Buy |
|
|||||
|
2020
Q4 | $3.01M | Buy |
|
|||||
|
2020
Q3 | $278K | Buy |
|
|||||
|
2020
Q2 | $65K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $606K | Sell |
|
|||||
|
2018
Q4 | $1.99M | Buy |
|
|||||
|
2018
Q3 | $9.67M | Sell |
|
|||||
|
2018
Q2 | $8.38M | Buy |
|
|||||
|
2018
Q1 | $6.24M | Buy |
|
|||||
|
2017
Q4 | $4.28M | Buy |
|
|||||
|
2017
Q3 | $7.13M | Buy |
|
|||||
|
2017
Q2 | $7.13M | Buy |
|
|||||
|
2017
Q1 | $3.5M | Sell |
|
|||||
|
2016
Q4 | $4.46M | Sell |
|
|||||
|
2016
Q3 | $4.39M | Buy |
|
|||||
|
2016
Q2 | $4.21M | Buy |
|